의학강좌 : 일차 진료의를 위한 효과적인 금연 치료법 = Effective Smoking-Cessation Strategies in Primary Care Setting

다국어 초록 (Multilingual Abstract)

Smoking leads to nicotine addiction and serious health problems and smoking cessation can reduce the risk of developing smoking-related diseases and premature death. Smoking is a chronic disease that requires repeated interventions, including counseling and pharmacotherapy. These are both effective for smoking cessation, but combined intervention is more effective than using either alone. Several first-line medications are effective and recommended for use, such as nicotine-replacement therapy (patch, gum, inhaler, lozenge, and nasal spray), bupropion SR, and varenicline. Special populations such as adolescent smokers, pregnant women, and smokers with mental illness can be treated with both counselling and medication. Physicians should recommend effective counselling and pharmacotherapy strategies to all smokers at every clinic visit. Insurance coverage for counselling and medications for quitting smoking are essential to reduce the smoking rate, especially in a primary care setting. (Korean J Med 2014;87:296-301)

참고문헌 (Reference)

1 Weiner E, "Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study" 129 : 94-95, 2011

2 Shiffman S, "Use of smoking-cessation treatments in the United States" 34 : 102-111, 2008

3 Fiore MC, "Treating tobacco use and dependence: clinical practice guideline" US Department of Health and Human Services, Public Health Service, Agency for Health Care policy and research 2000

4 Fiore MC, "Treating tobacco use and dependence: 2008 update-clinical practice guidelines" U.S. Department of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality 2008

5 Foulds J, "Treating tobacco dependence as a chronic illness and a key modifiable predictor of disease" 64 : 142-146, 2010

6 U.S. Department of Health and Human Services, "The health consequences of smoking - 50 years of progress: a report of the Surgeon General" U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health 2014

7 Papadakis S, "Strategies to increase the delivery of smoking cessation treatments in primary care settings: a systematic review and meta-analysis" 51 : 199-213, 2010

8 Glassman AH, "Smoking, smoking cessation, and major depression" 264 : 1546-1549, 1990

9 Schnoll RA, "Smoking cessation treatment by primary care physicians: an update and call for training" 31 : 233-239, 2006

10 Banham L, "Smoking cessation in severe mental illness: what works" 105 : 1176-1189, 2010

11 Breslau N, "Psychiatric comorbidity of smoking and nicotine dependence" 25 : 95-101, 1995

12 Stead LF, "Physician advice for smoking cessation" (2) : CD000165-, 2008

13 Richmond RL, "One-year evaluation of three smoking cessation interventions administered by general practitioners" 18 : 187-199, 1993

14 Korean Center for Disease Control and Prevention, "National survey of smoking rates"

15 "National Toxicology Program. Report on Carcinogens" U.S. Department of Health and Human Sciences, National Institute of Environmental Health Sciences, National Toxicology Program 2011

16 Rigotti NA, "Integrating comprehensive tobacco treatment into the evolving US health care system: it's time to act: comment on "a randomized trial of internet and telephone treatment for smoking cessation" 171 : 53-55, 2011

17 U.S. Department of Health and Human Services, "How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General" U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health 2010

18 Stead LF, "Group behavior therapy programmes for smoking cessation" (2) : CD001007-, 2005

19 Bullen C, "Electronic cigarettes for smoking cessation: a randomised controlled trial" 382 : 1629-1637, 2013

20 Jorenby DE, "Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial" 296 : 56-63, 2006

21 Agaku IT, "Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults-United States, 2005-2012" 63 : 29-34, 2014

22 Centers for Disease Control and Prevention, "Behavioral risk factor surveillance system prevalence and trends data, 2012" U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health 2013

23 Mills EJ, "Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation: a systematic review and metaanalysis of one hundred and twenty studies involving 177,390 individuals" 8 : 8-, 2010

24 Grana RA, "A longitudinal analysis of electronic cigarette use and smoking cessation" 174 : 812-813, 2014

25 Jha P, "21stcentury hazards of smoking and benefits of cessation in the United States" 368 : 341-350, 2013